Clinical Trial

Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain

Name: Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain — clinical trial record (NCT07159243)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multi-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and PK parameter of HL-1186 tablet for diabetic peripheral neuropathic pain.

Trial Details

NCT Number	NCT07159243
Lead Sponsor	Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Conditions	Diabetic Peripheral Neuropathic Pain
Enrollment	180 participants
Start Date	2025-09
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2025-09-08